MRS2698 is a selective P2Y2 agonist. MRS2698 has novel treatments for cardiovascular diseases, inflammatory diseases and neurodegeneration. References: Jacobson KA, Boeynaems JM. P2Y nucleotide receptors: promise of therapeutic applications. Drug Discov Today. 2010 Jul;15(13-14):570-8. doi: 10.1016/j.drudis.2010.05.011. Epub 2010 Jun 2. Review. PubMed PMID: 20594935; PubMed Central PMCID: PMC2920619.

纯度：≥98%

CAS：934014-05-8